Tonantzin G. Calvo

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Systemic rewiring of dendritic cells by melanoma-secreted midkine impairs immune surveillance and response to immune checkpoint blockade.

Systemic rewiring of dendritic cells by melanoma-secreted midkine impairs immune surveillance and response to immune checkpoint blockade.

Journal: Nature cancer
Published: March 17, 2023

Live imaging of neolymphangiogenesis identifies acute antimetastatic roles of dsRNA mimics.

Live imaging of neolymphangiogenesis identifies acute antimetastatic roles of dsRNA mimics.

Journal: EMBO molecular medicine
Published: June 11, 2020

Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state.

Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state.

Journal: Nature medicine
Published: June 28, 2019

p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors.

p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors.

Journal: Cancer cell
Published: July 18, 2017

Systems analysis identifies melanoma-enriched pro-oncogenic networks controlled by the RNA binding protein CELF1.

Systems analysis identifies melanoma-enriched pro-oncogenic networks controlled by the RNA binding protein CELF1.

Journal: Nature communications
Published: December 16, 2016

Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine.

Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine.

Journal: Nature
Published: March 10, 2016

Lineage-specific roles of the cytoplasmic polyadenylation factor CPEB4 in the regulation of melanoma drivers.

Lineage-specific roles of the cytoplasmic polyadenylation factor CPEB4 in the regulation of melanoma drivers.

Journal: Nature communications
Published: January 12, 2016

RAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma development.

RAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma development.

Journal: Oncotarget
Published: April 12, 2015

RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway.

RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway.

Journal: Cancer cell
Published: July 17, 2013
Showing 1-9 of 9

Last Updated: 09/26/2026